Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  23,914 results for ""Tegafur""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study.

  • Authors : Miyoshi T; Division of Thoracic Surgery, Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan.; Aokage K

Subjects: ErbB Receptors*/ErbB Receptors*/ErbB Receptors*/genetics ; Tegafur*/Tegafur*/Tegafur*/administration & dosage ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics

  • Source: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Nov 02; Vol. 54 (11), pp. 1185-1193.Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201).

  • Authors : Ogata Y; Department of Surgery, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, Fukuoka, 830-0011, Japan. .; Sadahiro S

Subjects: Tegafur*/Tegafur*/Tegafur*/administration & dosage ; Tegafur*/Tegafur*/Tegafur*/therapeutic use ; Uracil*/Uracil*/Uracil*/administration & dosage

  • Source: International journal of clinical oncology [Int J Clin Oncol] 2024 Sep; Vol. 29 (9), pp. 1284-1292. Date of Electronic Publication: 2024 Jun 04.Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A novel animal model of tegafur-induced hand-foot syndrome.

  • Authors : Takano-Mochizuki M; Global Drug Safety, Biopharmaceutical Assessment Unit, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan; Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8577, Japan. Electronic address: .

Subjects: Rats, Sprague-Dawley* ; Tegafur*/Tegafur*/Tegafur*/toxicity ; Disease Models, Animal*

  • Source: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2024 Jun; Vol. 487, pp. 116977. Date of Electronic Publication: 2024 May 22.Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Characterization of Forced Degradants of Tegafur, Gimeracil, and Oteracil Potassium by Liquid Chromatographic-Electrospray Ionization-Mass Spectrometry and Simultaneous Estimation of Triple Combination in Drug Substance and Finished Pharmaceutical Dosage Form.

  • Authors : Pal AK; Department of Pharmaceutical Analysis, GITAM Institute of Pharmacy, GITAM (Deemed to be University), Gandhi Nagar, Rushikonda, Visakhapatnam, Pin code: 530 045, Andhra Pradesh (State), India.; Raja S

Subjects: Tegafur*/Tegafur*/Tegafur*/analysis ; Pyridines*/Pyridines*/Pyridines*/analysis ; Spectrometry, Mass, Electrospray Ionization*/Spectrometry, Mass, Electrospray Ionization*/Spectrometry, Mass, Electrospray Ionization*/methods

  • Source: Archives of Razi Institute [Arch Razi Inst] 2024 Apr 30; Vol. 79 (2), pp. 287-302. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).Publisher: Razi Vaccine and Serum Research Institute Country of Publication: Iran NLM ID: 101549567 Publication Model: eCollection Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Novel Pharmaceutical Cocrystals of Tegafur: Synthesis, Performance, and Theoretical Studies.

  • Authors : Mei H; National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, People's Republic of China.; Wang N

Subjects: Tegafur* ; Models, Theoretical*; Crystallization

  • Source: Pharmaceutical research [Pharm Res] 2024 Mar; Vol. 41 (3), pp. 577-593. Date of Electronic Publication: 2024 Jan 30.Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study.

  • Authors : Wang X; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Feng G

Subjects: Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/therapy ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/pathology ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/mortality

  • Source: Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2417464. Date of Electronic Publication: 2024 Oct 27.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of neoadjuvant S-1-based chemoradiotherapy in resectable and borderline-resectable pancreatic cancer: a long-term follow-up study.

  • Authors : Shimane G; Department of Surgery, Keio University School of Medicine, 35 Shinano-Machi Shinjuku-Ku, Tokyo, 160-8582, Japan.; Kitago M

Subjects: Tegafur*/Tegafur*/Tegafur*/administration & dosage ; Tegafur*/Tegafur*/Tegafur*/therapeutic use ; Oxonic Acid*/Oxonic Acid*/Oxonic Acid*/administration & dosage

  • Source: World journal of surgical oncology [World J Surg Oncol] 2024 Dec 20; Vol. 22 (1), pp. 336. Date of Electronic Publication: 2024 Dec 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

Record details

Read More Add to Saved list
×
Academic Journal

Phase I study of neoadjuvant chemoradiotherapy with S-1 for clinically resectable type 4 or large type 3 gastric cancer in elderly patients aged 75 years and older (OGSG1303).

  • Authors : Shinkai M; Department of Surgery, Faculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.; Imano M

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/mortality

  • Source: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Dec 19; Vol. 42 (1), pp. 31. Date of Electronic Publication: 2024 Dec 19.Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X

Record details

Read More Add to Saved list
×
Academic Journal

Long-term outcomes of S-1 and oxaliplatin neoadjuvant chemotherapy with total mesorectal excision and lateral lymph node dissection for rectal cancer.

  • Authors : Morohashi H; Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki-shi, Aomori, 036-8562, Japan. .; Sakamoto Y

Subjects: Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/therapy ; Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/pathology ; Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/mortality

  • Source: BMC gastroenterology [BMC Gastroenterol] 2024 Dec 18; Vol. 24 (1), pp. 456. Date of Electronic Publication: 2024 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

Record details

Connect Read More Add to Saved list
×
Academic Journal

Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells.

  • Authors : Morimoto Y; Center for Education and Research on Clinical Pharmacy, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo, 194-8543, Japan. .; Takada K

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology ; Apoptosis*/Apoptosis*/Apoptosis*/drug effects

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Dec; Vol. 94 (6), pp. 763-774. Date of Electronic Publication: 2024 Sep 14.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  23,914 results for ""Tegafur""